Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma

Tang,Yi; Wang,Ya-Lan; Yang,Lian; Xu,Jian-Xia; Xiong,Wei; Xiao,Ming; Li,Ming

doi:10.3892/ijmm.2013.1370

Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma

Authors:
- Yi Tang
- Ya-Lan Wang
- Lian Yang
- Jian-Xia Xu
- Wei Xiong
- Ming Xiao
- Ming Li
View Affiliations

Affiliations: Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: May 8, 2013 https://doi.org/10.3892/ijmm.2013.1370
Pages: 130-136

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Poly(ADP-ribose) polymerase-1 (PARP-1) which mediates poly-ADP-ribosylation, has been extensively investigated in carcinoma compared to arginine ADP-ribosyltransferase 1 (ART1), which mediates mono‑ADP‑ribosylation. Previous studies have demonstrated that these enzymes promote proliferation and tumor development in colon carcinoma. However, whether there is any association between PARP-1 and ATR1 in colon carcinoma, remains unelucidated. In this study, using immunohistochemical analysis, we detected a higher expression of PARP-1 and ART1 in 63 samples from patients with colon carcinoma compared to 10 samples of normal colonic mucosa; our results revealed a positive correlation between the expression of PARP-1 and ART1 in the 63 human colon carcinoma tissue samples. To determine the correlation between PARP-1 and ART1, inhibitors of PARP-1 and ART1 and lentivirus vector‑mediated ART1 short‑hairpin RNA (shRNA) were used to culture CT26 murine colon adenocarcinoma cells separately. Using double‑label immunofluorescence assay, we detected the expression of PARP-1 in the CT26 cells, which was decreased following treatment with 5‑aminoisoquinolinone (5-AIQ, a PARP-1 inhibitor) or meta‑iodobenzylguanidine (MIBG, an ART1 inhibitor). However, the expression of ART1 only decreased when the CT26 cells were treated with MIBG. Furthermore, our results demonstrated that silencing ART1 inhibited PARP‑1 expression by decreasing the expression of nuclear factor-κB (NF-κB), inhibiting ras homolog A (RhoA). Hence, our data demonstrate the positive correlation between ART1 and PARP-1; the inhibition of ART1 activity downregulates PARP-1 expression by decreasing the activity of NF-κB in CT26 colon carcinoma cells.

View Figures

View References

1.	Hassa PO, Haenni SS, Elser M and Hottiger MO: Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev. 70:789–829. 2006. View Article : Google Scholar
2.	Moss J, Balducci E, Cavanaugh E, et al: Characterization of NAD: arginine ADP-ribosyltransferases. Mol Cell Biochem. 193:109–113. 1999. View Article : Google Scholar
3.	Zolkiewska A, Nightingale MS and Moss J: Molecular characterization of NAD: arginine ADP-ribosyltransferase from rabbit skeletal muscle. Proc Natl Acad Sci USA. 89:11352–11356. 1992. View Article : Google Scholar : PubMed/NCBI
4.	Corda D and Di Girolamo M: Functional aspects of protein mono-ADP-ribosylation. EMBO J. 22:1953–1958. 2003. View Article : Google Scholar : PubMed/NCBI
5.	Corda D and Di Girolamo M: Mono-ADP-ribosylation: a tool for modulating immune response and cell signaling. Sci STKE 2002. pe532002.PubMed/NCBI
6.	Helleday T, Bryant HE and Schultz N: Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy. Cell Cycle. 4:1176–1178. 2005. View Article : Google Scholar : PubMed/NCBI
7.	Hao LX, Wang YL and LI YY: Correlation of PARP expression with P-selectin and ICAM-1 expression in colorectal carcinoma. Basic Clin Med. 26:882–887. 2006.
8.	Li M, Cai L and Wang Y: Effect of poly(ADP-ribose) polymerase inhibition on liver metastasis of mouse colorectal carcinoma CR26 cell line in vivo. Acta Acad Med Mil Tert. 30:237–240. 2008.
9.	Wang YL and Hao LX: Effect of 5-aminoisoquinolinone on the adhesion of colon carcinoma. Chin J Cancer Res. 19:119–123. 2007. View Article : Google Scholar
10.	Effect of poly(ADP-ribose) polymerase inhibition on liver metastasis of mouse colorectal carcinoma CT26 cell line in vivo. Acta Acad Med Mil Tert. 29:1621–1624. 2008.
11.	Wang J, Nemoto E, Kots AY, Kaslow HR and Dennert G: Regulation of cytotoxic T cells by ecto-nicotinamide adenine dinucleotide (NAD) correlates with cell surface GPI-anchored/arginine ADP-ribosyltransferase. J Immunol. 153:4048–4058. 1994.PubMed/NCBI
12.	Wang J, Nemoto E and Dennert G: Regulation of CTL by ecto-nictinamide adenine dinucleotide (NAD) involves ADP-ribosylation of a p56lck-associated protein. J Immunol. 156:2819–2827. 1996.PubMed/NCBI
13.	Okamoto S, Azhipa O, Yu Y, Russo E and Dennert G: Expression of ADP-ribosyltransferase on normal T lymphocytes and effects of nicotinamide adenine dinucleotide on their function. J Immunol. 160:4190–4198. 1998.PubMed/NCBI
14.	Adriouch S, Ohlrogge W, Haag F, Koch-Nolte F and Seman M: Rapid induction of naive T cell apoptosis by ecto-nicotinamide adenine dinucleotide: requirement for mono(ADP-ribosyl) transferase 2 and a downstream effector. J Immunol. 167:196–203. 2001. View Article : Google Scholar : PubMed/NCBI
15.	Akai T, Nabeya Y, Yahiro K, et al: Helicobacter pylori induces mono-(adenosine 5′-diphosphate)-ribosylation in human gastric adenocarcinoma. Int J Oncol. 29:965–972. 2006.
16.	Yang L, Wang Y, Sheng Y, Xiong W, Xu J, Tang Y and Li X: The correlation of ART1 expression with angiogenesis in colorectal carcinoma and it relationship with VEGF and integrin αVβ3 expressions. Basic Clin Med. 9:1064–1069. 2012.
17.	Thyberg J, Hultgårdh-Nilsson A and Kallin B: Inhibitors of ADP-ribosylation suppress phenotypic modulation and proliferation of smooth muscle cells cultured from rat aorta. Differentiation. 59:243–252. 1995. View Article : Google Scholar : PubMed/NCBI
18.	Brac T and Ebisuzaki K: PolyADP ribosylation and Friend erythroleukemic-cell differentiation: action of poly(ADP-ribose) polymerase inhibitors. Differentiation. 34:139–143. 1987. View Article : Google Scholar : PubMed/NCBI
19.	Colon-Otero G, Sando JJ, Sims JL, McGrath E, Jensen DE and Quesenberry PJ: Inhibition of hemopoietic growth factor-induced proliferation by adenosine diphosphate-ribosylation inhibitors. Blood. 70:686–693. 1987.
20.	Francis G, Gray D, Berney J, Wing M, Guimaraes J and Hoffbrand A: Role of ADP-ribosyltransferase in differentiation of human granulocyte-macrophage progenitors to the macrophage lineage. Blood. 62:1055–1062. 1983.PubMed/NCBI
21.	Kuo ML, Chau YP, Wang JH and Shiah SG: Inhibitors of poly(ADP-ribose) polymerase block nitric oxide-induced apoptosis but not differentiation in human leukemia HL-60 cells. Biochem Biophys Res Commun. 219:502–508. 1996. View Article : Google Scholar : PubMed/NCBI
22.	Terada M, Fujiki H, Marks PA and Sugimura T: Induction of erythroid differentiation of murine erythroleukemia cells by nicotinamide and related compounds. Proc Natl Acad Sci USA. 76:6411–6414. 1979. View Article : Google Scholar : PubMed/NCBI
23.	Luo J, Kamata H and Karin M: IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest. 115:2625–2632. 2005. View Article : Google Scholar : PubMed/NCBI
24.	Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol. 18:621–663. 2000.PubMed/NCBI
25.	Virág L and Szabó C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev. 54:375–429. 2002.
26.	Pan J, Fauzee NJ, Wang YL, et al: Effect of silencing PARG in human colon carcinoma LoVo cells on the ability of HUVEC migration and proliferation. Cancer Gene Ther. 19:715–722. 2012. View Article : Google Scholar : PubMed/NCBI
27.	Loesberg C, van Rooij H and Smets LA: Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation). Biochim Biophys Acta. 1037:92–99. 1990. View Article : Google Scholar : PubMed/NCBI
28.	Mota-Filipe H, Sepodes B, McDonald M, Cuzzocrea S, Pinto R and Thiemermann C: The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat. Med Sci Monit. 8:BR444–BR453. 2002.PubMed/NCBI
29.	Fromowitz FB, Viola MV, Chao S, et al: Ras p21 expression in the progression of breast cancer. Hum Pathol. 18:1268–1275. 1987. View Article : Google Scholar : PubMed/NCBI
30.	Qin JM, Fu XY, Li SJ, et al: Gene and protein expressions of p28GANK in rat with liver regeneration. World J Gastroenterol. 9:2523–2527. 2003.PubMed/NCBI
31.	Kato J, Zhu J, Liu C, et al: ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis. Cancer Res. 71:5327–5335. 2011. View Article : Google Scholar : PubMed/NCBI
32.	Moss J, Stanley S, Nightingale M, et al: Molecular and immunological characterization of ADP-ribosylarginine hydrolases. J Biol Chem. 267:10481–10488. 1992.PubMed/NCBI
33.	Yau L, Litchie B, Thomas S, Storie B, Yurkova N and Zahradka P: Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression. Eur J Biochem. 270:101–110. 2003. View Article : Google Scholar
34.	Bourne HR, Sanders DA and McCormick F: The GTPase superfamily: conserved structure and molecular mechanism. Nature. 349:117–127. 1991. View Article : Google Scholar : PubMed/NCBI
35.	Hwang YS, Hodge JC, Sivapurapu N and Lindholm PF: Lysophosphatidic acid stimulates PC-3 prostate cancer cell matrigel invasion through activation of RhoA and NF-κB activity. Mol Carcinog. 45:518–529. 2006.PubMed/NCBI
36.	Cho SG, Li D, Stafford LJ, et al: KiSS1 suppresses TNFα-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-κB activation. J Cell Biochem. 107:1139–1149. 2009.
37.	Su X, Tang Z, Li Q, et al: Expression and significance of RhoA and NF-κB in human gastric carcinoma. Zhonghua Zhong Liu Za Zhi. 33:276–279. 2011.(In Chinese).
38.	Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R and Lacal JC: Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 11:463–475. 1997. View Article : Google Scholar : PubMed/NCBI